Andreas Stefferl
Partner
Dr. rer. nat., Mag. rer. nat. (Biology), German and European Patent Attorney, UPC Representative 言語 DE | EN バイオテクノロジー・チーム Encrypted E-mail to Andreas Stefferl
詳しくはこちらお問い合わせ
T +49 89 92 40 90
E astefferl@hoffmanneitle.com
Arabellastraße 30
81925 München
A straight-talking team player
Andreas Stefferl is a partner in HOFFMANN EITLE’s Biotechnology practice group. He gained his scientific spurs at the University of Vienna (Austria), University of Manchester (UK) and the Max Planck Institute for Neurobiology and Psychiatry (Germany). After obtaining his PhD in the field of neuroimmunology, Andreas acquired business insights as a research analyst at a rating agency and as an investment manager at a venture capital firm specialized on biotech startup companies.
Andreas is qualified as a German and European Patent Attorney since 2007. His European qualification comes to fruition in supervising EPO prosecution and portfolio management, as well as in leading contested proceedings before the EPO. His national qualification is the foundation for Andreas’ litigation activities before the German courts in nullity and infringement proceedings and his participation in international litigation teams. His cases span a wide field of biotechnological inventions, with a focus on antibodies, stem cell biology and fermentative production methods of fine chemicals.
Whilst being outspoken about his views, Andreas enjoys working in larger teams, oftentimes bridging the cultural and legal diversity across different continents. His main client base is European and Japanese.
As a past-time, Andreas likes to spend time on the water sailing, or in his garden.
Opinion work; examination, opposition and appeal proceedings before the European and German Patent Offices and before the Federal Patent Court, mainly in the field of biotechnological inventions.
- Mag. rer. nat. in biology, University of Vienna
- Dr. rer. nat. in biology, University of Vienna
- German Patent Attorney (2008)
- European Patent Attorney (2007)
- Representative before the Unified Patent Court (2023)
- German Patent Attorney Bar Association
- epi
iam 1000: Stefferl “handles EPO proceedings with similar poise“ and “brings significant business nous to the table, thanks to stints as an investment manager at a venture capital firm and a research analyst at a rating agency and recommends him individually for prosecution and nullity.”